Parametrica Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Parametrica Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,970	Closed	-$223K	–	188
2022 Q2	$223K	Buy	+2,970	New	+$132K	0.24%	115

Parametrica Management's TPTX Position: Q3 2022 in Review

Parametrica Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 2,970 shares — an estimated $223K sold.

Parametrica Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $223K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Parametrica Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Parametrica Management sold 2,970 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $223K.
Parametrica Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Parametrica Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $223K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.